Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria
PLOS One · 12.06.2026 · 21 (6) · e0351492
DOI: 10.1371/journal.pone.0351492 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 12.06.2026. Verfasst von Ifeoma Jovita Nduka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria. Hauptthemen laut MEDLINE: Mammography, Cost-Benefit Analysis, Breast Neoplasms, Early Detection of Cancer. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society of Tropical Medicine and Hygiene.
Abstract (Originalsprache)
Mammography still remains the gold standard for breast cancer screening, considering its impact on breast cancer mortality. However, it has a relatively low utilization rate in Nigeria. Although the National Strategic Cancer Control Plan (NSCCP) has a goal of making screening services and early detection of cancer available for all Nigerians, there is currently no national breast cancer screening program implemented in Nigeria. The modelling study aimed to evaluate the cost-effectiveness of mammography screening from the healthcare provider’s perspective and to determine the appropriate screening interval for Nigerian women, aiming to enhance the efficiency and effectiveness of breast cancer detection programs. A state-transition Markov model was adapted to simulate annual and biennial mammography, breast cancer diagnosis, and treatment in a cohort of cancer-free Nigerian women aged 40 years and followed them for a lifetime. The study was conducted from the healthcare provider’s perspective. Disability-adjusted life year (DALY) averted, representing the health outcomes, was used to estimate the incremental cost-effectiveness ratio (ICER). Costs and outcomes were discounted at an annual rate of 5%. Annual mammography screening costs US$238.60, averted a DALY of 1.060, and was the most cost-effective intervention with an ICER of US$207.24 (95% CI US$213.31 – US$216.88)/DALY averted, which was below the willingness-to-pay threshold of $1074. Mammography screening strategies were estimated to be cost-effective from the healthcare payer’s perspective under the model assumptions. Annual screening showed the most favorable cost-effectiveness profile among the strategies evaluated, but this finding is model-dependent and should be interpreted as comparative economic evidence rather than a definitive screening recommendation. These results can inform future research, policy discussions, and consideration of sustainable financing for breast cancer screening in Nigeria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
- Centre for Health Services Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Qld Australia.
- Division of Population Health, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
ORCID-Profile: Ifeoma Jovita Nduka
Förderung
- Royal Society of Tropical Medicine and Hygiene
Zitieren
APA
Nduka, I. J., Okafor, C. E., & Ekwunife, O. I. (2026). Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria. PLOS One, 21(6), e0351492. https://doi.org/10.1371/journal.pone.0351492
Vancouver
Nduka IJ, Okafor CE, Ekwunife OI. Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria. PLOS One. 2026;21(6):e0351492. doi:10.1371/journal.pone.0351492
BibTeX
@article{Nduka2026,
author = {Nduka, Ifeoma Jovita and Okafor, Charles Ebuka and Ekwunife, Obinna Ikechukwu},
title = {Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0351492},
doi = {10.1371/journal.pone.0351492}
}
EUVIMED